Skip to content

Ny behandling af bartholins cyste/abscess med sølvnitrat

Ny behandling af bartholins cyste/abscess med sølvnitrat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000494-22-DK
Enrollment
Unknown
Registered
2005-06-14
Start date
2005-07-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bartholins cyste/abscess

Interventions

Trade Name: Lapispenna Product Name: Lapispenna Pharmaceutical Form: Wound stick Concentration unit: g gram(s) Concentration number: 0.35-

Sponsors

Department of Obstetrics and Gynecolog, Randers Centralsygehusy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Women from 18 to 60 years, who should be able to read and speak Danish. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Women, who does not want to parcipite to the study.

Design outcomes

Primary

MeasureTime frame
Main Objective: The purpose of the study is to evaluate the efficacy of silver nitrate application in patients with Bartholins cysts or abscesses. By using this treatment it is expected to find lower frequency of recurrence and dysparonia then usual technique, marsupialisation.;Secondary Objective: By application of silver nitrate, which is simple and cheap treatment of Bartholins cyste/abscesses, it is expected to avoid pain of long duration, scarring, bleeding, infektion, recurrent drenage, risk of general anaesthesia, need for extra personal and equipment.;Primary end point(s): Low frequency of recurrence and dysparonia.

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026